Abiopharma

🔍 CESAN RAUL E (Director)

Company: GARTNER INC (IT)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 162 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 30,445.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Family Trust #1 | shares_owned_after: 18,400.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Family Trust #2 | shares_owned_after: 28,900.00
• Acquired 162 shares of Common Stock Equivalents (CSE) (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,225.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 162 shares of Common Stock Equivalents (CSE) (Derivative)
  Date: 2026-04-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 1,063.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: This reporting person has elected to receive an immediate distribution of the CSE shares.
• F2: These are Common Stock Equivalents ("CSEs") received as compensation for service as an outside director of Gartner, Inc. They were granted under the Gartner, Inc. Long-Term Incentive Plan ("LTIP"). The CSEs convert into Gartner common stock on the date the outside director's continuous status as a director terminates, or as otherwise provided in the LTIP.